
Neurologist

No OPD information available
Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS)
Thrombectomy
Bipolar Disorder (BPD)
CACH Syndrome
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dysarthria
Encephalitis
Heart Transplant
Kidney Transplant
Neuromyelitis Optica
Optic Neuritis
Stent Placement
Stroke
Transient Ischemic Attack (TIA)
Transverse Myelitis
Tuberculous Meningitis
Suzanne J. Hodgkinson is a female healthcare provider who helps people with different health conditions like Multiple Sclerosis, Bipolar Disorder, Stroke, and more. She is skilled in treating these conditions and has special training to help her patients feel better.
Suzanne talks to her patients in a kind and caring way. She listens to their concerns and explains things clearly. Patients trust her because she is knowledgeable and shows she cares about their well-being.
To stay updated, Suzanne reads new medical information and attends conferences. This helps her learn about the latest treatments and research so she can give the best care to her patients.
Suzanne works well with other medical professionals. She shares ideas and collaborates with colleagues to provide the best care possible. This teamwork approach helps patients get the treatment they need.
Suzanne's work has made a positive impact on many patients' lives. Her treatments have helped people feel better and manage their health conditions. Patients appreciate her dedication and the improvements they see in their health.
One of Suzanne's notable publications talks about a new way to measure progression in Multiple Sclerosis. She also took part in a clinical trial to test a new treatment for Progressive Multiple Sclerosis, showing her commitment to finding better ways to help patients.
In summary, Suzanne J. Hodgkinson is a caring and knowledgeable healthcare provider who uses her skills to help patients with various health conditions. She stays updated with the latest medical knowledge, works well with colleagues, and has made a positive impact on many lives through her treatments and research efforts.
Enrollment Status: Terminated
Published: February 23, 2024
Intervention Type: Drug, Biological
Study Drug: ATA188
Study Phase: Phase 1/Phase 2
